Exploring the prevalence and types of fall-risk-increasing drugs among older people with upper limb fractures
Objectives
Medications and specifically fall-risk-increasing drugs (FRIDs) are associated with increased risk of falls: reducing their prescription may improve this risk. This study explored patient characteristics associated with FRID use, prevalence and type of FRIDs and changes in their prescriptions among older people with arm fractures over 6 months.
Methods
Observational prospective study in three fracture clinics in England. Patients aged ≥65 years with a single upper limb fragility fracture were recruited. The STOPPFall tool identified the number and type of FRIDs prescribed at baseline, 3- and 6-month follow-ups. Changes in FRID prescription were categorised as discontinued, new or exchanged.
Key findings
100 patients (median age 73 years; 80% female) were recruited. At baseline, 73% used ≥1 FRID daily (median = 2), reducing to 64% and 59% at 3 and 6 months, respectively. Those with >1 FRID prescription had a significantly higher number of co-morbidities and medications and higher rates of male gender, polypharmacy, frailty and sarcopenia. The most frequently prescribed FRIDs were antihypertensives, opioids and antidepressants. Between 0 and 3 months, 44 (60%) participants had changes to FRID prescription: 20 discontinued (opioids and antihistamines), 13 started (antidepressants) and 11 exchanged for another. Similar trends were observed at 6 months.
Conclusion
Use of FRIDs among older people with upper limb fragility fractures was high. Although overall use decreased over time, 59% were still on ≥1 FRID at the 6-month follow-up, with trends to stop opioids and start antidepressants. Older people presenting with upper limb fractures should be offered a structured medication review to identify FRIDs for targeted deprescribing.
Top-30
Journals
|
1
2
|
|
|
International Journal of Pharmacy Practice
2 publications, 13.33%
|
|
|
Journal of the American Geriatrics Society
1 publication, 6.67%
|
|
|
Journal of Evidence-Based Medicine
1 publication, 6.67%
|
|
|
Journal of the American Medical Directors Association
1 publication, 6.67%
|
|
|
BMC Geriatrics
1 publication, 6.67%
|
|
|
Acta Pharmaceutica
1 publication, 6.67%
|
|
|
Research in Social and Administrative Pharmacy
1 publication, 6.67%
|
|
|
Geriatrics (Switzerland)
1 publication, 6.67%
|
|
|
Sensors
1 publication, 6.67%
|
|
|
Applied Nursing Research
1 publication, 6.67%
|
|
|
Expert Review of Clinical Pharmacology
1 publication, 6.67%
|
|
|
Pharmacy
1 publication, 6.67%
|
|
|
Age and Ageing
1 publication, 6.67%
|
|
|
1
2
|
Publishers
|
1
2
3
4
|
|
|
Wiley
4 publications, 26.67%
|
|
|
Elsevier
3 publications, 20%
|
|
|
MDPI
3 publications, 20%
|
|
|
Springer Nature
1 publication, 6.67%
|
|
|
Walter de Gruyter
1 publication, 6.67%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 6.67%
|
|
|
Taylor & Francis
1 publication, 6.67%
|
|
|
Oxford University Press
1 publication, 6.67%
|
|
|
1
2
3
4
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.